Overview

The Hematologic Malignancies Program of the Mayo Clinic Cancer Center conducts research about cancers of the blood and bone marrow.

The Hematologic Malignancies Program has three main goals:

  • Investigating the epidemiology and mechanisms of progression for hematologic malignancies
  • Characterizing the cell biology and molecular nature of hematologic malignancies to identify new therapeutic targets
  • Developing new therapies for hematologic malignancies

The Hematologic Malignancies Program also participates in a Specialized Program of Research Excellence (SPORE) grant for lymphoma.